Courtagen raises $8M for biomarker work

Massachusetts-based Courtagen has raised $8 million from 67 investors to support development of protein biomarkers for disease detection using technology it bought from Decision Biomarkers in 2009, according to Xconomy. The company was previously known as Avantra Bioscience. Article

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.